I J Mackie|C B Colaco|S J Machin - JoVE Visualize

Showing results (71-80 of 231) with videos related to

Pageof 24

Sort By:

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 27, 2002

An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificityC Gardiner, P C Cooper, M Makris, et al.

Journal of Thrombosis and Haemostasis : JTH|April 9, 2015

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndromeD R J Arachchillage, I J Mackie, M Efthymiou, et al.

Contraception|September 1, 1990

Changes in metabolism induced by oral contraceptives containing desogestrel and gestodene in older womenG E Robinson, W Bounds, I J Mackie, et al.

Thrombosis and Haemostasis|August 6, 2000

Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnanciesS Donohoe, J C Kingdom, I J Mackie, et al.

Journal of Thrombosis and Haemostasis : JTH|September 9, 2014

Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndromeD R J Arachchillage, M Efthymiou, I J Mackie, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990

Heparin cofactor II levels are increased by the use of combined oral contraceptivesI J Mackie, H Segal, T Burren, et al.

Lancet (London, England)|May 30, 2001

Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trialJ H Scurr, S J Machin, S Bailey-King, et al.

British Journal of Haematology|July 10, 2001

Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-overI J Mackie, K Piegsa, S A Furs, et al.

British Journal of Haematology|March 18, 2008

The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunctionS K Austin, R D Starke, A S Lawrie, et al.

Thrombosis Research|January 4, 2015

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolismD R J Arachchillage, M Efthymiou, I J Mackie, et al.

Pageof 24

Showing results (71-80 of 231) with videos related to

Sort By:

Pageof 24

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 27, 2002

An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificityC Gardiner, P C Cooper, M Makris, et al.

Journal of Thrombosis and Haemostasis : JTH|April 9, 2015

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndromeD R J Arachchillage, I J Mackie, M Efthymiou, et al.

Contraception|September 1, 1990

Changes in metabolism induced by oral contraceptives containing desogestrel and gestodene in older womenG E Robinson, W Bounds, I J Mackie, et al.

Thrombosis and Haemostasis|August 6, 2000

Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnanciesS Donohoe, J C Kingdom, I J Mackie, et al.

Journal of Thrombosis and Haemostasis : JTH|September 9, 2014

Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndromeD R J Arachchillage, M Efthymiou, I J Mackie, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990

Heparin cofactor II levels are increased by the use of combined oral contraceptivesI J Mackie, H Segal, T Burren, et al.

Lancet (London, England)|May 30, 2001

Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trialJ H Scurr, S J Machin, S Bailey-King, et al.

British Journal of Haematology|July 10, 2001

Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-overI J Mackie, K Piegsa, S A Furs, et al.

British Journal of Haematology|March 18, 2008

The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunctionS K Austin, R D Starke, A S Lawrie, et al.

Thrombosis Research|January 4, 2015

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolismD R J Arachchillage, M Efthymiou, I J Mackie, et al.

Pageof 24